Inflammatory Orofacial Disorders and Granulomatous Conditions

Inflammatory orofacial disorders encompass a spectrum of conditions characterised by chronic inflammation of the lips, oral mucosa and adjacent facial tissues. Central to this group is orofacial granulomatosis, in which non-caseating granulomas—aggregates of activated macrophages—form in response to immune dysregulation, microbial triggers or genetic susceptibility. These granulomatous lesions may arise in isolation or in association with systemic diseases such as Crohn’s disease, sarcoidosis and mixed connective tissue disorders. Melkersson–Rosenthal syndrome represents a related entity defined by recurrent facial swelling, facial palsy and a fissured tongue, underscoring overlap between neuro-mucocutaneous and granulomatous processes. Clinical presentation varies from isolated lip oedema and gingival swelling to multisystem involvement, posing diagnostic challenges. Recent advances in immunophenotyping, microbiome analysis and genetic profiling have refined our understanding of pathogenesis, highlighted potential biomarkers and informed targeted therapeutic approaches including corticosteroids, immunomodulators and dietary interventions. Improved awareness and multidisciplinary collaboration are essential for early recognition, accurate diagnosis and optimal management of these globally significant conditions.

Research from Nature Portfolio

A recent comparative study of paediatric-onset orofacial granulomatosis and Crohn’s disease revealed distinct patterns in faecal microbiota and host genetics. Children with isolated orofacial granulomatosis showed reduced abundance of Clostridia alongside enrichment of Actinobacteria and Bacilli, with specific increases in Bifidobacterium adolescentis and decreases in Faecalibacterium prausnitzii correlating with oral disease severity. Genetic analysis further identified a higher frequency of a key NOD2 allele in orofacial granulomatosis versus Crohn’s cohorts, supporting the concept of orofacial granulomatosis as a distinct clinical phenotype. These findings open avenues for non-invasive microbial biomarkers and genotype-guided risk stratification.

Inflammatory Orofacial Disorders and Granulomatous Conditions publication trend

The graph below shows the total number of articles in inflammatory orofacial disorders and granulomatous conditions across all publications each year (not limited to Nature Index journals).

Technical terms

Orofacial granulomatosis: A chronic inflammatory condition characterised by non-caseating granulomas in the lips and oral mucosa.

Granuloma: A compact collection of immune cells, primarily macrophages, formed in response to persistent inflammation or infection.

Monocyte: A type of white blood cell that differentiates into macrophages and dendritic cells to orchestrate inflammatory responses.

Neutrophil extracellular traps (NETs): Web-like structures composed of DNA and antimicrobial proteins expelled by neutrophils to trap pathogens.

Faecal microbiota: The community of microorganisms residing in the gastrointestinal tract, influencing immune function and systemic health.

References

1. Differential activation of monocytes and PMNs in orofacial granulomatosis patients induced by bacterial and non-bacterial stimuli. Frontiers in Immunology (2025).
2. Fecal microbiota and genetics in pediatric-onset orofacial granulomatosis and Crohn´s disease. Scientific Reports (2025).
3. Melkersson–Rosenthal Syndrome in Childhood: Report of Three Paediatric Cases and a Review of the Literature. International Journal of Environmental Research and Public Health (2019).
4. Immunophenotype in orofacial granulomatosis with and without Crohn’s disease. Medicina Oral Patología Oral y Cirugia Bucal (2014).
5. Orofacial Granulomatosis among Pediatric Patients Well Controlled by Corticosteroid Treatment: A Rare Case Series. Case Reports in Pediatrics (2024).